AL-LAD

• Description :

  AL-LAD (6-Allyl-6-nor-LSD) is an activator for 5-HT2A receptor with Ki of 3.4-8.1 nM. AL-LAD exhibits affinity for dopamine receptor D1 and dopamine receptor D2 with absolute affinitiesK0.5 of 189 nM and 12.3 nM. AL-LAD acts as psychoactive substance in mouse model[1].

• Product Name Alternative :

  6-Allyl-6-nor-LSD

• UNSPSC :

  12352005

• Hazard Statement :

  H225-H302+H312+H332-H319

• Target :

  5-HT Receptor; Dopamine Receptor

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Smiles :

  [H][C@@]1(CC2=CNC3=CC=CC4=C23)C4=C[C@H](CN1CC=C)C(N(CC)CC)=O

• Molecular Formula :

  C22H27N3O

• Molecular Weight :

  349.47

• Precautions :

  P210-P233-P240-P241-P242-P243-P261-P264-P270-P271-P280-P302+P352-P303+P361+P353-P304+P340-P305+P351+P338-P330-P362+P364-P370+P378-P403+P235-P501

• References & Citations :

  [1]Brandt SD, et al., Return of the lysergamides. Part II: Analytical and behavioural characterization of N6 -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S) -lysergic acid 2,4-dimethylazetidide (LSZ) . Drug Test Anal. 2017 Jan;9 (1) :38-50.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  5-HT2 Receptor; D1 Receptor; D2 Receptor; α-1 microglobulin

• CAS Number :

  [65527-61-9]